IN2013MU01160A - - Google Patents

Info

Publication number
IN2013MU01160A
IN2013MU01160A IN1160MU2013A IN2013MU01160A IN 2013MU01160 A IN2013MU01160 A IN 2013MU01160A IN 1160MU2013 A IN1160MU2013 A IN 1160MU2013A IN 2013MU01160 A IN2013MU01160 A IN 2013MU01160A
Authority
IN
India
Prior art keywords
gatifloxacin
amorphous
provides
stable
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Abhay Tatiya
Ajinkya Chandratre
Sushil Kumar Yadav
Ismail Farooqui
Vikas Chandra Rai
Pankaj Kumar Naithani
Arvind Yekanathsa Merwade
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1160MU2013 priority Critical patent/IN2013MU01160A/en
Publication of IN2013MU01160A publication Critical patent/IN2013MU01160A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1160MU2013 2013-03-26 2013-03-26 IN2013MU01160A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1160MU2013 IN2013MU01160A (es) 2013-03-26 2013-03-26

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1160MU2013 IN2013MU01160A (es) 2013-03-26 2013-03-26

Publications (1)

Publication Number Publication Date
IN2013MU01160A true IN2013MU01160A (es) 2015-04-24

Family

ID=54395450

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1160MU2013 IN2013MU01160A (es) 2013-03-26 2013-03-26

Country Status (1)

Country Link
IN (1) IN2013MU01160A (es)

Similar Documents

Publication Publication Date Title
PH12016501122A1 (en) Delayed release compositions of linaclotide
EP3082817A4 (en) Compositions for drug administration
EP3096763A4 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
EP2982367A4 (en) PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION CONTAINING DONEPEZIL
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
WO2014153495A3 (en) Novel stat3 inhibitors
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
IN2013MU03641A (es)
IN2013MU00646A (es)
WO2014076712A3 (en) Lurasidone hydrochloride solid dispersion
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
IN2013MU01985A (es)
IN2013MU03862A (es)
EP3020417A4 (en) Pharmaceutical composition for respiratory administration
IN2013MU01111A (es)
IL245260A0 (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
EP3041478A4 (en) Vaccine compositions for drug addiction
IN2013CH04314A (es)
IN2013MU03565A (es)
IN2013MU03422A (es)
IN2013MU01226A (es)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2013MU01160A (es)